PYRROLO[2,3-F]INDAZOLE AND 2,4,5,10-TETRAZATRICYCLO[7.3.0.03,7]DODECA-1,3(7),5,8,11-PENTAENE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD)

Pyrrolo[2,3-f]indazole and 2,4,5,10-tetrazatricyclo[7.3.0.03,7]dodeca-1,3(7),5,8,11-pentaene derivatives as alpha-l-antitrypsin modulators for treating alpha-l-antitrypsin deficiency (AATD)

Saved in:
Bibliographic Details
Main Authors HALL, Amy B, COTTRELL, Kevin Michael, BRODNEY, Michael Aaron, BOYD, Michael John, ZAKY, Mariam, GARCIA BARRANTES, Pedro Manuel, HURLEY, Dennis James, BOUCHER, Diane Marie, MAXWELL, John Patrick, FIMOGNARI, JR., Robert Francis, XU, Jinwang, JOHNSON, JR., Mac Arthur, DAMAGNEZ, Veronique, KESAVAN, Sarathy, GREY, JR., Ronald Lee, JONES, Peter, TAPLEY, Timothy Lewis, THOMSON, Stephen A, FANNING, Lev T., D, SWETT, Rebecca Jane, GIROUX, Simon, NUHANT, Philippe Marcel
Format Patent
LanguageEnglish
French
German
Published 08.02.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Pyrrolo[2,3-f]indazole and 2,4,5,10-tetrazatricyclo[7.3.0.03,7]dodeca-1,3(7),5,8,11-pentaene derivatives as alpha-l-antitrypsin modulators for treating alpha-l-antitrypsin deficiency (AATD)
Bibliography:Application Number: EP20210722013